The pharmacological treatment of acquired nystagmus.Pract Neurol. 2012 Jun; 12(3):147-53.PN
Abstract
We review the latest literature on the neuropharmacological treatments for acquired nystagmus.Nystagmus may have a significant [corrected] impact on health, yet there is little scientific evidence on which to make firm recommendations for treatment. Acquired pendular nystagmus may respond to gabapentin or memantine; downbeat and upbeat nystagmus to aminopyridines; and periodic alternating nystagmus to baclofen. To improve treatment we need multi-centre, randomised controlled trials using standardised techniques in reporting objective outcomes, with good follow-up duration and careful reporting of side effects.
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
22661344
Citation
Mehta, Arpan R., and Christopher Kennard. "The Pharmacological Treatment of Acquired Nystagmus." Practical Neurology, vol. 12, no. 3, 2012, pp. 147-53.
Mehta AR, Kennard C. The pharmacological treatment of acquired nystagmus. Pract Neurol. 2012;12(3):147-53.
Mehta, A. R., & Kennard, C. (2012). The pharmacological treatment of acquired nystagmus. Practical Neurology, 12(3), 147-53. https://doi.org/10.1136/practneurol-2011-000181
Mehta AR, Kennard C. The Pharmacological Treatment of Acquired Nystagmus. Pract Neurol. 2012;12(3):147-53. PubMed PMID: 22661344.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - The pharmacological treatment of acquired nystagmus.
AU - Mehta,Arpan R,
AU - Kennard,Christopher,
PY - 2012/6/5/entrez
PY - 2012/6/5/pubmed
PY - 2013/4/5/medline
SP - 147
EP - 53
JF - Practical neurology
JO - Pract Neurol
VL - 12
IS - 3
N2 - We review the latest literature on the neuropharmacological treatments for acquired nystagmus.Nystagmus may have a significant [corrected] impact on health, yet there is little scientific evidence on which to make firm recommendations for treatment. Acquired pendular nystagmus may respond to gabapentin or memantine; downbeat and upbeat nystagmus to aminopyridines; and periodic alternating nystagmus to baclofen. To improve treatment we need multi-centre, randomised controlled trials using standardised techniques in reporting objective outcomes, with good follow-up duration and careful reporting of side effects.
SN - 1474-7766
UR - https://www.unboundmedicine.com/medline/citation/22661344/The_pharmacological_treatment_of_acquired_nystagmus_
L2 - https://pn.bmj.com/lookup/pmidlookup?view=long&pmid=22661344
DB - PRIME
DP - Unbound Medicine
ER -